Granulocyte-colony stimulating factor (filgrastim) accelerates granulocyte recovery after intensive postremission chemotherapy for acute myeloid leukemia with aziridinyl benzoquinone and mitoxantrone: Cancer and Leukemia Group B study 9022. (Q33498419)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Granulocyte-colony stimulating factor (filgrastim) accelerates granulocyte recovery after intensive postremission chemotherapy for acute myeloid leukemia with aziridinyl benzoquinone and mitoxantrone: Cancer and Leukemia Group B study 9022. |
scientific article |
Statements
1 reference
Granulocyte-colony stimulating factor (filgrastim) accelerates granulocyte recovery after intensive postremission chemotherapy for acute myeloid leukemia with aziridinyl benzoquinone and mitoxantrone: Cancer and Leukemia Group B study 9022. (English)
1 reference
Moore JO
1 reference
Dodge RK
1 reference
Amrein PC
1 reference
Kolitz J
1 reference
Lee EJ
1 reference
Powell B
1 reference
Godfrey S
1 reference
Robert F
1 reference
Schiffer CA
1 reference
1 February 1997
1 reference
1 reference
780-788
1 reference
Identifiers
1 reference